The European Medicines Agency (EMA) on Tuesday said it would hold an extraordinary meeting on December 29 to consider emergency approval for a vaccine developed by Germany’s BioNTech and US giant Pfizer. READ MORE
Coronavirus India lockdown day 252 live updates | 59% will not rush to take COVID-19 vaccine, finds survey
0 Comments